Skip to main content
Home Resources

Resources

Search
Refine Results
Page 1 of 1 (9 Results)
Clinical Guidelines
CRA living guidelines for the pharmacological management of rheumatoid arthritis with disease-modifying anti-rheumatic drugs
This Canadian Rheumatology Association (CRA) guideline provides contemporary recommendations for the pharmacological management of rheumatoid arthritis (RA) with disease-modifying anti-rheumatic drug (DMARD) therapy. Recommendations are developed using the GRADE approach with a multidisciplinary panel composed of rheumatologists, researchers, methodologists, and […]
April 23, 2026
Read Guideline (opens in new tab)
Clinical Guidelines
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Guideline for the Management of Axial Spondyloarthritis
The management of axial spondyloarthritis (axSpA) is a complex and rapidly changing field for Canadian rheumatologists. The Spondyloarthritis Research Consortium of Canada (SPARCC) and the Canadian Rheumatology Association (CRA) last updated treatment recommendations for the management of axSpA in 2014(1,2). […]
April 22, 2026
Read Guideline (opens in new tab)
Clinical Guidelines
CRA/CanRIO guidelines for the management of baseline immunosuppression in individuals with pre-existing rheumatic diseases initiating immune checkpoint inhibitors
This living guideline offers up-to-date guidance on the management of baseline immunosuppression (IS) for pre-existing rheumatic diseases (PRDs) when initiating cancer immunotherapy with immune checkpoint inhibitors (ICIs). Split into 2 parts, this guideline provides contemporary baseline IS recommendations for individuals […]
September 1, 2025
Read Guideline (opens in new tab)
Clinical Guidelines
The CRA living guidelines for the Screening, Monitoring and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis
Recommendations were developed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE)-Adolopment approach... Provider Infographic
October 23, 2022
Read Guideline (opens in new tab)
Clinical Guidelines
Updated CRA Recommendation on COVID-19 Vaccination in Persons with Autoimmune Rheumatic Disease
The Canadian Rheumatology Association guideline panel suggests using COVID-19 vaccination in persons aged 12 and older with autoimmune rheumatic disease...
November 23, 2021
Download
Download
Clinical Guidelines
CRA Recommendation on Three Doses of mRNA Vaccine for Preventing COVID-19
The Canadian Rheumatology Association guideline panel suggests using a third dose of mRNA COVID-19 vaccination [BNT 162b2 (Pfizer-BioNTech) or mRNA-1273 (Moderna)] in persons aged 18 and older with autoimmune rheumatic disease...
November 23, 2021
Download
Download
Clinical Guidelines
Canadian Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus
Recommendations were developed using the GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach...
September 23, 2018
Read Guideline (opens in new tab)
Clinical Guidelines
Canadian Recommendations for the Management of Spondyloarthropathy
The Canadian Rheumatology Association (CRA) and the Spondyloarthritis Research Consortium of Canada (SPARCC) have collaborated to update the recommendations for the management of spondyloarthritis (SpA)...
April 1, 2014
Read Guideline
Clinical Guidelines
Canadian Recommendations for Management of RA
The CRA has developed 2011/2012 recommendations for the pharmacological management of RA that take into consideration Canada’s current healthcare system. The recommendations address treatment questions identified from a national needs assessment survey of Canadian rheumatology professionals and are published in […]
August 1, 2012
Read Guideline (opens in new tab)